Proinflammatory role of leptin in experimental colitis in rats benefit of cholecystokinin-B antagonist and beta3-agonist.

Barbier, M; Attoub, S; Joubert, M; Bado, A; Laboisse, C; Cherbut, C; Galmiche, J P

Barbier, M; Attoub, S; Joubert, M; Bado, A; Laboisse, C; Cherbut, C; Galmiche, J P.

Affiliation

Barbier M; Centre de Recherche en Nutrition Humaine, INSERM Unité 539, CHU Hotel Dieu, et INRA, Nantes, France.

Life Sci ; 69(5): 567-80, 2001 Jun 22.

Article in En | MEDLINE | ID: mdl-11510951

Subject(s)

Adrenergic beta-Agonists/therapeutic use; Colitis/drug therapy; Hormone Antagonists/therapeutic use; Leptin/metabolism; Adrenergic beta-3 Receptor Agonists; Analysis of Variance; Animals; Benzodiazepines/therapeutic use; Colitis/metabolism; Colitis/physiopathology; Disease Models, Animal; Ethanolamines/therapeutic use; Inflammatory Bowel Diseases/etiology; Inflammatory Bowel Diseases/metabolism; Leptin/blood; Male; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Adrenergic, beta-3/physiology; Receptors, Cholecystokinin/antagonists & inhibitors; Receptors, Cholecystokinin/physiology; Severity of Illness Index

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Colitis / Adrenergic beta-Agonists / Leptin / Hormone Antagonists Type of study: Etiology_studies / Prognostic_studies Limits: Animals Language: En Year: 2001 Type: Article

Search on Google

XML

PubMed Links